On Nov 3, 2021 Notable closed a Series B round and raised $100,000,000 from F-Prime Capital, Greylock, ICONIQ Growth, Oak HC/FT, featuring lead investors ICONIQ […]
Series C – Biond Biologics
On Nov 3, 2021 Biond Biologics closed a Series C round and raised $15,000,000 from Deep Insight, Harel Insurance Investments and Financial Services, Heritage Group, […]
Series B – BrainCheck
On Nov 3, 2021 BrainCheck closed a Series B round and raised $10,000,000 from Next Coast Ventures, Nueterra Capital, S3 Ventures, SelectQuote Insurance Services, Tensility […]
Seed Round – Dogsee Chew
On Nov 3, 2021 Dogsee Chew closed a Seed round and raised $7,000,000 from Sixth Sense Ventures, featuring lead investors Sixth Sense Ventures. About the […]
Venture Round – Illumigyn
On Nov 3, 2021 Illumigyn closed a Venture – Series Unknown round and raised $33,000,000 from Ubicom Holdings, Yozma Group, featuring lead investors Ubicom Holdings, […]
SuitX acquired by Ottobock
Nov 2, 2021 Ottobock has entered into an agreement to acquire SuitX . Ottobock based at Duderstadt, Niedersachsen, Germany. “Ottobock is the leading innovator for […]
Guidemark Health acquired by Arsenal Capital Partners
Nov 2, 2021 Arsenal Capital Partners has entered into an agreement to acquire Guidemark Health . Arsenal Capital Partners based at New York, New York, […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Series D – Antiva Biosciences
On Nov 2, 2021 Antiva Biosciences closed a Series D round and raised $31,000,000 from Adjuvant Capital, Alexandria Venture Investments, Avestria Ventures, Brace Pharma, Canaan […]
Series B – Biolinq
On Nov 2, 2021 Biolinq closed a Series B round and raised $100,000,000 from Able Partners, Aphelion Capital, Ascensia Diabetes Care, AXA Investment Managers, Cirrus […]
